July 14, 2005 -- In this multi-part series, we look at technological advances that have given rise to new areas of drug research. At the moment, the latest new thing is stem cells and we continue our analysis of individual stem cell companies, discussing their history, their clinical focus, and their drug candidates. In this section, we discuss Novocell, StemCells, Titan Pharma, and Transition Therapeutics...
